Category

Pharmaceutical 6677 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

FDA clears redesigned duodenoscope

duodenoscope

The Food and Drug Administration (FDA) has approved the first duodenoscope with a disposable distal cap, a redesigned version of a previous model of specialized endoscope designed to reduce the risk of transmitting infections from patient-to-patient. The Pentax ED34-i10T duodenscope, which is an upgrade from the Pentax ED-3490TK duodenoscope, is intended to enable doctors to visualize and access the upper gastrointestinal tract to treat bile duct disorders and other upper gastrointestinal problems. Duodenoscopes are flexible, lighted devices that are threaded through the mouth of a patient and into the top of the small intestine. The devices have many small parts ... Read More

Teens given opioids more likely to be persistent users

opioid, oxycodone - Shutterstock

Teenagers are being given opioid painkillers long-term after surgery, signaling a potential risk for abuse and misuse of the high-dependence drugs, according to a study to be presented at the American Academy of Pediatrics 2017 National Conference and Exhibition. The study involved the analysis of more than 88,000 privately insured patients aged 13-21 who had undergone one of 13 common surgeries and, prior to surgery, had never been treated with opioids. A group of similar patients with no surgeries or opioid use was used as the control group. Researchers found that the incidence of new persistent opioid use – defined as ... Read More

Supplements laced with dangerous ingredients recalled

ucm576793

Gadget Island Inc., doing business as Gear Isle, is recalling four brands of dietary supplements because they are laced with several hidden drugs that can cause life-threatening side effects in some people. The recall affects the following Gadget Island supplements: Rhino 7 Platinum 5000, UPC 617135861224, LOT# R7-D5K1011H Papa Zen 3000, UPC 718122032587, LOT# NSS050888 Fifty Shades 6000, UPC 4026666146056, LOT# No Lot Number Grande X 5800, UPC 640793555440, LOT# No Lot Number A Food and Drug Administration (FDA) laboratory analysis has determined the supplements to contain undeclared sildenafil, tadalafil and desmethyl carbodenafil. Sildenafil and tadalafil are the active ingredients ... Read More

Do most melanomas come from preexisting moles?

melanoma

A recent study published in the Journal of the American Academy of Dermatology looked to see if most melanomas come from preexisting moles as is often believed. The researchers performed a systematic review and meta-analysis to determine the incidence and prevalence of nevus-associated melanoma, or melanoma associated with preexisting moles. They analysed 38 observational cohort and case-control studies, more than 20,000 melanomas, and found that only 29.1 percent likely were associated with preexisting moles. Seventy-one percent arose de novo, or started from new. Melanomas associated with preexisting moles were not as thick, and the patients with those moles were younger by ... Read More

New program to test supplements sold online

computer security login1

A new model made possible by e-commerce can help reassure consumers that the dietary supplements they buy online do not contain hidden or dangerous ingredients. The program provides independent testing of products through sites that analyze, rank, and sell their products – information the consumer has access to. The cost for testing the supplements is built into the sales price from referral links. Nearly 90 percent of supplements and vitamins are sold offline by companies such as GNC and Herbalife, but e-commerce is beginning to win consumers over. The verification program can offer consumers peace of mind that the supplement ... Read More

Man blames AndroGel for his heart attack

androgel-pump

Attorneys for a man suing AbbVie Inc., maker of AndroGel, told an Illinois federal jury that the drug company never tested its testosterone replacement therapy to rule out if it could cause heart problems, Law360 reported. Otherwise plaintiff Jeffrey Konrad would never have taken the drug, they said. Konrad’s case is the second bellwether trial in a multidistrict litigation (MDL) taking aim at testosterone manufacturers. AbbVie, as the maker of the top selling AndroGel, is the first drug maker to sit in the hot seat. The first trial against AbbVie ended in a $150 million in punitive damages for the ... Read More

Medical device linked to infection in child heart patients

heartbeat

At least a dozen children who had heart surgery at Children’s Hospital in New Orleans from late May to June developed infections at the incision site. The problem is linked to a temperature-regulating device used during their procedures, said Dr. John Heaton, the hospital’s senior vice president and chief medical officer. The machine has since been replaced and the infected patients are being treated with intravenous antibiotics, he said. Doctors were alerted to the problem after three incision infections were reported within 72 hours in children who had undergone heart surgery at Children’s. The infections were caused by a common ... Read More

Women open up on Instagram about hair loss

bald woman, Taxotere - Pixabay image

September is Alopecia Areata Awareness Month. NewBeauty honors the month by reposting several women’s Instagram posts where they open up about their experiences with alopecia and show photos of themselves just as they are, without wigs or hats. Alopecia is the medical term for hair loss and can be used to describe those who experience hair loss for a variety of reasons. Alopecia can be caused by genetics, which is often called pattern hair loss, and risk generally increases with age. An autoimmune disease known as alopecia areata can affect those of any age and often appears in childhood. It ... Read More

Apricot kernel extract linked to cyanide poisoning

apricots - Pixabay

A 67-year-old man who took apricot kernel extract for five years to keep his prostate cancer from returning developed cyanide poisoning that had begun to starve his internal organs of oxygen. The man was put under anesthesia for routine surgery when his doctor discovered he had low oxygen saturation. Blood test later showed levels of cyanide in his blood. The man admitted to taking two teaspoons of self-prepared apricot kernel extract and three tablets of Novodalin, an herbal fruit kernel supplement, every day for the past five years. A laboratory analysis on the supplements found that he had been consuming 17.32mg of toxic cyanide ... Read More

Two deaths reported in trial of new RA drug

clinical trial, research test tubes

Drug company AbbVie Inc., touted promising clinical trial results with its potential best-in-class rheumatoid arthritis treatment, but two patient deaths cast a dark shadow over the news, BioPharma Dive reported. The experimental drug ABT-494, known chemically as upadacitinib, is in a class of medications called Janus kinase (JAK) inhibitors. The drug is designed for patients with moderate-to-severe rheumatoid arthritis, or RA, who are not adequately treated by the standard biologics. The phase 3 SELECT-BEYOND clinical trial tested the drug at both 15mg and 30mg doses, and its primary endpoint of reducing the symptoms of RA by 20 percent over 12 ... Read More